v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Conversion of Convertible Debt
At-the-Market Offering
Common Stock
Common Stock
Conversion of Convertible Debt
Common Stock
At-the-Market Offering
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of Convertible Debt
Additional Paid-in Capital
At-the-Market Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024       11,043,837                
Beginning balance at Dec. 31, 2024 $ (11,312)     $ 110     $ (150) $ 183,004     $ (175) $ (194,101)
Treasury stock, beginning balance (in shares) at Dec. 31, 2024             (14,455)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock, net of issuance costs (in shares)           106,823            
Issuance of common stock, net of issuance costs     $ 835     $ 1       $ 834    
Exercise of stock options (in shares)       1,628                
Issuance of common stock upon exercise of options 7             7        
Conversion of senior note payable into common stock (in shares)         3,500,573              
Conversion of senior note payable into common stock   $ 20,176     $ 35       $ 20,141      
Issuance of common stock and warrants from the January Offering (in shares)       1,261,830                
Issuance of common stock and warrants from the January Offering 9,143     $ 13       9,130        
Issuance of common stock upon settlement of restricted stock and common warrants (in shares)       68,500                
Issuance of common stock upon settlement of restricted stock and common warrants 716     $ 1       715        
Stock-based compensation 517             517        
Foreign currency translation adjustment 31                   31  
Net loss (11,209)                     (11,209)
Balance at end of period (in shares) at Mar. 31, 2025       15,983,191                
Ending balance at Mar. 31, 2025 $ 8,904     $ 160     $ (150) 214,348     (144) (205,310)
Treasury stock, ending balance (in shares) at Mar. 31, 2025             (14,455)          
Balance at beginning of period (in shares) at Dec. 31, 2025 17,800,307     17,814,762                
Beginning balance at Dec. 31, 2025 $ 1,636     $ 178     $ (150) 235,407     (127) (233,672)
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 (14,455)           (14,455)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock, net of issuance costs (in shares)           819,157            
Issuance of common stock, net of issuance costs     $ 7,777     $ 8       $ 7,769    
Exercise of stock options (in shares) 20,431     20,431                
Issuance of common stock upon exercise of options $ 100             100        
Stock-based compensation 868             868        
Foreign currency translation adjustment 5                   5  
Net loss $ (11,823)                     (11,823)
Balance at end of period (in shares) at Mar. 31, 2026 18,639,895     18,654,350                
Ending balance at Mar. 31, 2026 $ (1,437)     $ 186     $ (150) $ 244,144     $ (122) $ (245,495)
Treasury stock, ending balance (in shares) at Mar. 31, 2026 (14,455)           (14,455)